EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantifying the Diagnosis and Survival of Early Onset Bowel Cancer Among First Nations Peoples in Queensland, Australia

Tsegaw Amare Baykeda iD, Shafkat Jahan iD, Kirsten Howard iD, Rakhee Raghunandan iD, Gail Garvey iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Tsegaw Amare Baykeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Faculty of Health, Medicine and Behavioural Science, The University of Queensland, Brisbane, Australia. Hauptthemen laut MEDLINE: Early Detection of Cancer, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Centre of Research Excellence (CRE) in Targeted Approaches To Improve Cancer Services for Aboriginal and Torres Strait Islander Australians.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The incidence of early‐onset bowel cancer (EOBC) is increasing in Australia and globally. However, the burden of EOBC among First Nations Australians is rarely determined. This study aimed to quantify the diagnosis and survival rates of EOBC among First Nations Peoples in Queensland, Australia.

Methods

CancerCostMod, a linked administrative dataset of patients diagnosed with cancer in Queensland from 1st July 2011 to 30th June 2015, was used. EOBC was defined as a diagnosis of bowel cancer (i.e., colon, rectosigmoid, or rectal cancer) at 18–49 years of age. A multivariable logistic regression analysis was employed to determine the association of Indigenous status and other factors with a diagnosis of EOBC. Five‐year survival rates were used to estimate the survival rate.

Results

Of 11,702 bowel cancer cases, 9.2% (95% CI: 8.7%–9.7%) were EOBC, with 19% among First Nations peoples and 9% among Non‐First Nations. First Nations Australians had 2.6 times the odds of EOBC diagnosis (95% CI: 1.7–4.0) compared with Non‐First Nations Australians. Overall, EOBC patients showed a significantly higher 5‐year survival rate of 77% compared with 60% for late‐onset bowel cancer patients. However, First Nations EOBC patients showed a lower 5‐year survival rate (73%) than Non‐First Nations EOBC patients (77%).

Conclusion

First Nations Australians have more than double the diagnosis rates and lower 5‐year survival for EOBC compared to Non‐First Nations. Whilst the recent lowering of the age eligibility for the National Bowel Cancer Screening Program is a beneficial strategy to address the increasing incidence of EOBC, special consideration should be given to addressing the higher diagnosis rates and lower survival among First Nations Australians. This study raises the potential for further lowering the age eligibility for First Nations Australians to ensure younger First Nations Australians can access screening for earlier detection, thereby improving their survival from bowel cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerColorectal NeoplasmsAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultAge of OnsetIncidenceQueenslandSurvival RateAustralian Aboriginal and Torres Strait Islander Peoples

Stichwörter der Autor:innen

First Nations Indigenous Australiansaboriginal and Torres Strait islander peoplesbowel cancerearly onset bowel canceryoung‐onset bowel cancer

Autor:innen und Institutionen

  • School of Public Health, Faculty of Health, Medicine and Behavioural Science, The University of Queensland, Brisbane, Australia.
  • The Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

ORCID-Profile: Tsegaw Amare Baykeda, Shafkat Jahan, Kirsten Howard, Rakhee Raghunandan, Gail Garvey

Förderung

  • National Health and Medical Research Council
  • Centre of Research Excellence (CRE) in Targeted Approaches To Improve Cancer Services for Aboriginal and Torres Strait Islander Australians

Zitieren

APA

Baykeda, T. A., Jahan, S., Howard, K., Raghunandan, R., & Garvey, G. (2025). Quantifying the Diagnosis and Survival of Early Onset Bowel Cancer Among First Nations Peoples in Queensland, Australia. Cancer Medicine. https://doi.org/10.1002/cam4.70821

Vancouver

Baykeda TA, Jahan S, Howard K, Raghunandan R, Garvey G. Quantifying the Diagnosis and Survival of Early Onset Bowel Cancer Among First Nations Peoples in Queensland, Australia. Cancer Medicine. 2025. doi:10.1002/cam4.70821

BibTeX
@article{Baykeda2025,
  author = {Baykeda, Tsegaw Amare and Jahan, Shafkat and Howard, Kirsten and Raghunandan, Rakhee and Garvey, Gail},
  title = {Quantifying the Diagnosis and Survival of Early Onset Bowel Cancer Among First Nations Peoples in Queensland, Australia},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70821}
}
Kostenlos starten →